PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW122545View Pathway |
signaling
chebulagic acid Metabolism 1550463482 1563965617Homo sapiens
|
Creator: Guest: Anonymous Created On: July 24, 2019 at 04:54 Last Updated: July 24, 2019 at 04:54 |
PW123844View Pathway |
chebulagic acid MetabolismAcinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)
|
Creator: Guest: Anonymous Created On: March 26, 2020 at 04:33 Last Updated: March 26, 2020 at 04:33 |
PW126006View Pathway |
biosynthesis novo 1621425491Homo sapiens
|
Creator: Guest: Anonymous Created On: May 19, 2021 at 05:58 Last Updated: May 19, 2021 at 05:58 |
PW124724View Pathway |
biosynthesis novo 1618594753Homo sapiens
Hola
|
Creator: Guest: Anonymous Created On: April 16, 2021 at 11:39 Last Updated: April 16, 2021 at 11:39 |
PW124614View Pathway |
biosynthesis novo 1617096865Homo sapiens
|
Creator: Guest: Anonymous Created On: March 30, 2021 at 03:34 Last Updated: March 30, 2021 at 03:34 |
PW124389View Pathway |
biosynthesis novo 1607575986Homo sapiens
|
Creator: Guest: Anonymous Created On: December 09, 2020 at 21:53 Last Updated: December 09, 2020 at 21:53 |
PW124357View Pathway |
biosynthesis novo 1606168250Homo sapiens
|
Creator: Guest: Anonymous Created On: November 23, 2020 at 14:50 Last Updated: November 23, 2020 at 14:50 |
PW124344View Pathway |
biosynthesis novo 1605518331Homo sapiens
|
Creator: Guest: Anonymous Created On: November 16, 2020 at 02:19 Last Updated: November 16, 2020 at 02:19 |
PW124252View Pathway |
biosynthesis novoHomo sapiens
|
Creator: Guest: Anonymous Created On: October 19, 2020 at 17:50 Last Updated: October 19, 2020 at 17:50 |
PW122243View Pathway |
disease
AspartylglucosaminuriaHomo sapiens
Aspartylglucosaminuria (AGU) is an inherited disease that is characterized by a decline in mental functioning, accompanied by an increase in skin, bone and joint issues. The disease is caused by a defect in an enzyme known as aspartylglucosaminidase (normally present in the liver and brain as well as other tissues). This enzyme plays a significant role in our bodies because it aids in breaking down certain sugars (for example, oligosaccharides) that are attached to specific proteins (for example, glycoproteins). Aspartylglucosaminuria itself is characterized as a lysosomal disease because it does deal with inadequate activity in an enzyme's function. Aspartylglucosaminidase functions to break down glycoproteins. These proteins are most abundant in the tissues of the body and in the surfaces of major organs, such as the liver, spleen, thyroid and nerves. When glycoproteins are not broken down, aspartylglucosaminidase backs up in the lysosomes along with other substances. This backup causes progressive damage to the tissues and organs. Aspartylglucosaminuria is a genetic condition that is inherited from both parents. The AGU patient is born with two copies of the mutated AGA gene. One copy comes from the mother’s egg and the other copy comes from the father’s sperm. In order to develop aspartylglucosaminuria, the individual must inherit changes in both of his AGU genes (autonomic recessive inheritance). When a person receives one changed form of the gene AGU from one of the parents, the individual is then classified as a carrier [Wikipedia].
|
Creator: xuan cao Created On: October 01, 2018 at 11:15 Last Updated: October 01, 2018 at 11:15 |